news_image.jpg

Treatment success for diabetic kidney disease

16 Apr 2019



Clinical trial findings in The New England Journal of Medicine report that canagliflozin can reduce the risk of kidney and cardiac failure in patients with diabetes.

iNews



Issue 44 - Summer 2019 - DSD

Latest Newsletter

Issue 44 - Summer 2019 - DSD

Issue 44 - Summer 2019 - DSD

Newsletter Archive

Previous newsletters can be viewed and downloaded from the archive.

Newsletter Archive